JP2005537010A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2005537010A5 JP2005537010A5 JP2004532878A JP2004532878A JP2005537010A5 JP 2005537010 A5 JP2005537010 A5 JP 2005537010A5 JP 2004532878 A JP2004532878 A JP 2004532878A JP 2004532878 A JP2004532878 A JP 2004532878A JP 2005537010 A5 JP2005537010 A5 JP 2005537010A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- fragment
- nucleotide
- identification
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000012634 fragment Substances 0.000 claims 161
- 239000002773 nucleotide Substances 0.000 claims 136
- 125000003729 nucleotide group Chemical group 0.000 claims 136
- 238000000034 method Methods 0.000 claims 57
- 201000000980 schizophrenia Diseases 0.000 claims 28
- 238000011156 evaluation Methods 0.000 claims 6
- 210000000349 chromosome Anatomy 0.000 claims 2
- 150000007523 nucleic acids Chemical class 0.000 claims 2
- 102000039446 nucleic acids Human genes 0.000 claims 2
- 108020004707 nucleic acids Proteins 0.000 claims 2
- 108700028369 Alleles Proteins 0.000 claims 1
- 238000012408 PCR amplification Methods 0.000 claims 1
- 230000003321 amplification Effects 0.000 claims 1
- 102000054766 genetic haplotypes Human genes 0.000 claims 1
- 238000005259 measurement Methods 0.000 claims 1
- 238000003199 nucleic acid amplification method Methods 0.000 claims 1
Claims (56)
(1)601及び2106、
(2)194及び2106、
(3)194及び601、
(4)1038及び2106、
(5)601、1038及び2106、
(6)601、1038及び2185、
(7)194、1038及び2106、
(8)194、601及び1038、
(9)194、1038及び2185、
(10)601、1038及び2359、
(11)194、601及び2106、
(12)194、601及び1038、
(13)601、2106及び2359、
(14)601、2106及び2185、
(15)601、1038及び2106、
(16)601、1038及び2359、
(17)194、601及び2106、
(18)601、1038、2106及び2185、
(19)194、601、1038及び2106、
(20)194、1038、2106及び2185、
(21)194、601、1038及び2185、
(22)601、1038、2185及び2359、
(23)601、1038、2106及び2359、
(24)194、1038、2185及び2359、並びに
(25)194、601、1038及び2359
にある多型部位からなる群より選ばれる2以上のSeq−40多型部位を占めるヌクレオチドに対応する核酸由来のヌクレオチドを測定することを含む、診断又は予知の目的のための個体のハプロタイプ決定方法。 Position of SEQ ID NO: 1 on a single chromosome:
(1) 601 and 2106,
(2) 194 and 2106,
(3) 194 and 601,
(4) 1038 and 2106,
(5) 601, 1038 and 2106,
(6) 601, 1038 and 2185,
(7) 194, 1038 and 2106,
(8) 194, 601 and 1038,
(9) 194, 1038 and 2185,
(10) 601, 1038 and 2359,
(11) 194, 601 and 2106,
(12) 194, 601 and 1038,
(13) 601, 2106 and 2359,
(14) 601, 2106 and 2185,
(15) 601, 1038 and 2106,
(16) 601, 1038 and 2359,
(17) 194, 601 and 2106,
(18) 601, 1038, 2106 and 2185,
(19) 194, 601, 1038 and 2106,
(20) 194, 1038, 2106 and 2185,
(21) 194, 601, 1038 and 2185,
(22) 601, 1038, 2185 and 2359,
(23) 601, 1038, 2106 and 2359,
(24) 194, 1038, 2185 and 2359, and (25) 194, 601, 1038 and 2359.
A method for determining the haplotype of an individual for diagnostic or prognostic purposes, comprising measuring a nucleotide derived from a nucleic acid corresponding to a nucleotide occupying two or more Seq-40 polymorphic sites selected from the group consisting of the polymorphic sites .
(1)601及び1038、
(2)194及び1038、
(3)601及び2106、
(4)194及び2106、
(5)194及び601、
(6)1038及び2106、
(7)601、1038及び2106、
(8)601、1038及び2185、
(9)194、1038及び2106、
(10)194、601及び1038、
(11)194、1038及び2185、
(12)601、1038及び2359、
(13)194、601及び2106、
(14)194、601及び1038、
(15)601、2106及び2359、
(16)601、2106及び2185、
(17)601、1038及び2106、
(18)601、1038及び2359、
(19)194、601及び2106、
(20)601、1038、2106及び2185、
(21)194、601、1038及び2106、
(22)194、1038、2106及び2185、
(23)194、601、1038及び2185、
(24)601、1038、2185及び2359、
(25)601、1038、2106及び2359
(26)194、1038、2185及び2359、並びに
(27)194、601、1038及び2359
に1以上のSeq−40多型部位を占めるヌクレオチドに対応する患者から得られた核酸由来のヌクレオチドを測定方法であって、当該測定結果が、当該患者が精神分裂病を発症する傾向があるか否かを評価するために用いられる、前記方法。 Position of SEQ ID NO: 1 on a single chromosome:
(1) 601 and 1038,
(2) 194 and 1038,
(3) 601 and 2106,
(4) 194 and 2106,
(5) 194 and 601,
(6) 1038 and 2106,
(7) 601, 1038 and 2106,
(8) 601, 1038 and 2185,
(9) 194, 1038 and 2106,
(10) 194, 601 and 1038,
(11) 194, 1038 and 2185,
(12) 601, 1038 and 2359,
(13) 194, 601 and 2106,
(14) 194, 601 and 1038,
(15) 601, 2106 and 2359,
(16) 601, 2106 and 2185,
(17) 601, 1038 and 2106,
(18) 601, 1038 and 2359,
(19) 194, 601 and 2106,
(20) 601, 1038, 2106 and 2185,
(21) 194, 601, 1038 and 2106,
(22) 194, 1038, 2106 and 2185,
(23) 194, 601, 1038 and 2185,
(24) 601, 1038, 2185 and 2359,
(25) 601, 1038, 2106 and 2359
(26) 194, 1038, 2185 and 2359, and (27) 194, 601, 1038 and 2359.
Is a method for measuring nucleotides derived from a nucleic acid obtained from a patient corresponding to a nucleotide occupying one or more Seq-40 polymorphic sites, and the measurement result indicates that the patient tends to develop schizophrenia Said method used to evaluate whether or not.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US40643202P | 2002-08-28 | 2002-08-28 | |
US10/230,007 US20030170667A1 (en) | 2001-08-28 | 2002-08-28 | Single nucleotide polymorphisms diagnostic for schizophrenia |
PCT/US2003/024799 WO2004020580A2 (en) | 2002-08-28 | 2003-08-26 | Single nucleotide polymorphisms diagnostic for schizophrenia |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2005537010A JP2005537010A (en) | 2005-12-08 |
JP2005537010A5 true JP2005537010A5 (en) | 2006-10-12 |
Family
ID=31980950
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2004532878A Withdrawn JP2005537010A (en) | 2002-08-28 | 2003-08-26 | Single nucleotide polymorphism diagnosis of schizophrenia |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1546398A4 (en) |
JP (1) | JP2005537010A (en) |
AU (1) | AU2003261460A1 (en) |
WO (1) | WO2004020580A2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2006023719A2 (en) * | 2004-08-20 | 2006-03-02 | Enh Research Institute | Identification of snp’s associated with schizophrenia, schizoaffective disorder and bipolar disorder |
US7932042B1 (en) | 2010-10-13 | 2011-04-26 | Suregene, Llc | Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001036473A2 (en) * | 1999-11-16 | 2001-05-25 | Pharmacia & Upjohn Company | Human g protein-coupled receptors |
WO2002064789A1 (en) * | 2001-02-14 | 2002-08-22 | Pharmacia & Upjohn Company | Protein-coupled receptor |
AU2002324711A1 (en) * | 2001-08-28 | 2003-03-18 | Pharmacia And Upjohn Company | Single nucleotide polymorphisms diagnostic for schizophrenia |
-
2003
- 2003-08-26 WO PCT/US2003/024799 patent/WO2004020580A2/en not_active Application Discontinuation
- 2003-08-26 EP EP03791659A patent/EP1546398A4/en not_active Withdrawn
- 2003-08-26 JP JP2004532878A patent/JP2005537010A/en not_active Withdrawn
- 2003-08-26 AU AU2003261460A patent/AU2003261460A1/en not_active Abandoned
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20190002979A1 (en) | Haplotyping of hla loci with ultra-deep shotgun sequencing | |
JP3693352B2 (en) | Methods for detecting genetic polymorphisms and monitoring allelic expression using probe arrays | |
JP2014533949A5 (en) | ||
JP2012525147A5 (en) | ||
KR20070011354A (en) | Detection of strp, such as fragile x syndrome | |
JP2011530306A5 (en) | ||
JP2010520745A5 (en) | ||
US20110312534A1 (en) | Method for prediction of human iris color | |
JP2009504153A (en) | Method and / or apparatus for oligonucleotide design and / or nucleic acid detection | |
CN102618549B (en) | NCSTN mutant gene, and its identification method and tool | |
WO2017193044A1 (en) | Noninvasive prenatal diagnostic | |
TW201936921A (en) | A primer for next generation sequencer and a method for producing the same, a DNA library obtained through the use of a primer for next generation sequencer and a method for producing the same, and a DNA analyzing method using a DNA library | |
JP2010510804A5 (en) | ||
KR102275752B1 (en) | Method and kit for determining the genome integrity and/or the quality of a library of dna sequences obtained by deterministic restriction site whole genome amplification | |
JP2010035532A (en) | Method for allele-specific pcr | |
US20100297633A1 (en) | Method of amplifying nucleic acid | |
JP2008148612A (en) | Tool for identifying chicken variety and use thereof | |
Ghedira et al. | Assessment of primer/template mismatch effects on real-time PCR amplification of target taxa for GMO quantification | |
WO2006091757A3 (en) | Detection of very virulent infectious bursal disease virus | |
KR101929163B1 (en) | Kit for Diagnosing Charcot-Marie-Tooth | |
US20210340611A1 (en) | Digital polymerase chain reaction method for detecting nucleic acids in samples | |
KR101921027B1 (en) | Kit for Diagnosing Charcot-Marie-Tooth | |
JP2005537010A5 (en) | ||
JP2002325581A (en) | Method for detecting unknown or known nucleic acid mutation using nucleic acid melt curve and nucleic acid dissociation curve, and exhibition method thereof | |
KR101929165B1 (en) | Kit for Diagnosing Charcot-Marie-Tooth |